Skip to main content

Leukemia

Leukemia, Oncology
CPX-351 Improves Posttransplant Survival in Older Patients with High-Risk Acute Myeloid Leukemia
Phoebe Starr
Read More
Leukemia, Oncology
Strategies to Reduce the Use of Tyrosine Kinase Inhibitors in CML
Phoebe Starr
Read More
Leukemia, Oncology
Chemotherapy-Free Induction with Ibrutinib plus Rituximab Shows Unprecedented Efficacy in MCL
Charles Bankhead
Read More
Leukemia, Oncology
Refining the Use of CAR T-Cells in Patients with Acute Lymphoblastic Leukemia
Phoebe Starr
Read More
Leukemia, Oncology
CAR T-Cell Therapy Produces High Response Rates in Refractory B-Cell Malignancies
Wayne Kuznar
Read More
Leukemia, Oncology
Nilotinib Yields Better Rates of Molecular Response Than Imatinib in Frontline Setting
Chase Doyle
Read More
Leukemia, Oncology
Ibrutinib a New Standard of Care for Elderly Patients with Chronic Lymphocytic Leukemia
Phoebe Starr
Read More
Leukemia, Oncology
Idelalisib Improves Survival When Added to Bendamustine plus Rituximab in Patients with CLL
Phoebe Starr
Read More
Leukemia, Oncology
Immunotherapy with Blinatumomab Prolongs Survival in Acute Lymphoblastic Leukemia
Chase Doyle
Read More
Leukemia, Oncology
Adding Ibrutinib to Standard Therapy Reduces Disease Progression by 80% in Previously Treated Patients with CLL
Phoebe Starr
Read More
Page 4 of 7
Results 31 - 40 of 70